COMMUNIQUÉS West-GlobeNewswire

Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73 in Alzheimer’s Disease at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
26/10/2018
Late-Breaking Data Demonstrate Significant Association Between Higher ANAVEX®2-73 Concentration and Maintained Activities of Daily Living and Reduced Cognitive Decline in Alzheimer’s Disease Patients Data Confirm [...]
Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimer’s Disease (CTAD)
26/10/2018
Three- and four-year data continued to show reduction in amyloid plaque and to suggest a slowing of the rate of clinical decline in patients CAMBRIDGE, Mass., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and [...]
Neuralstem Announces $2.1 Million Registered Direct Offering
26/10/2018
GERMANTOWN, Md., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced that it has entered into [...]
Adamas to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 1, 2018
26/10/2018
EMERYVILLE, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Oral semaglutide demonstrates statistically significant reductions in HbA1c and body weight in people with long duration of type 2 diabetes treated with insulin
26/10/2018
Bagsværd, Denmark, 26 October 2018 - Novo Nordisk today announced the headline results from PIONEER 8, a phase 3a trial with oral semaglutide for the treatment of adults with type 2 diabetes. Oral semaglutide is an [...]
CrownBio lance MuBase® 2.0, une base de données en libre accès de modèles murins en immuno-oncologie
26/10/2018
Les mises à jour mettent en valeur l'expérience d'utilisateur, fournissent des données complètes de caractérisation et ajoutent de nouveaux modèles SAN DIEGO, 26 oct. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, société [...]
Diversicare to Announce Third Quarter 2018 Financial Results on Thursday, November 1, 2018
26/10/2018
BRENTWOOD, Tenn., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its third quarter ended September 30, 2018, on [...]
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition -- CFN Media
26/10/2018
SEATTLE, Oct. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer
26/10/2018
BRIDGEWATER, N.J., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy Hanna as Chief Commercial [...]
RAMSAY GENERALE DE SANTE to complete the public offer to the shareholders of Capio
26/10/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCES [...]
RAMSAY GENERALE DE SANTE finalise avec succès l'offre publique d'achat faite aux actionnaires de Capio
26/10/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]
XBiotech Announces New Patents for Third Quarter 2018
26/10/2018
Patents Granted/Allowed for Company’s Candidate Treatments for Cardiovascular Disease, Staphylococcus Aureus Infections and its Antibody Discovery Technology AUSTIN, Texas, Oct. 26, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc [...]
Sharecare to join Governor Nathan Deal, Walmart, BlueCross BlueShield of Georgia and Emory Healthcare for announcement about improving health of Georgia’s workforce
26/10/2018
ATLANTA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Sharecare founder Jeff Arnold will join Georgia Governor Nathan Deal and leaders from the Georgia Department of Community Health, Walmart, BlueCross BlueShield of Georgia and [...]
Aeglea BioTherapeutics to Present Preclinical Data on a New Pipeline Therapeutic for Cystinuria in an Oral Presentation at the 2018 American Society of Nephrology (ASN) Annual Meeting
26/10/2018
AEB5100 is an Engineered Human Enzyme with Novel Cystine Degrading Activity Presentation Today at 5:54 p.m. PT at the 2018 American Society of Nephrology (ASN) Annual Meeting AUSTIN, Texas, Oct. 26, 2018 (GLOBE NEWSWIRE [...]
Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in Patients with Glut1 DS with Disabling Movement Disorders
26/10/2018
Ultragenyx discontinuing development of UX007 in Glut1 DS indication Company on track with separate UX007 program in LC-FAOD with pre-NDA meeting later this year NOVATO, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- [...]
Media Advisory: Unlocking the Potential of the Health and Life Sciences Sector
26/10/2018
OTTAWA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Canada’s Hospital CEOs and Vice-Presidents of health research will join Paul-Émile Cloutier, President and CEO of HealthCare CAN – the national voice of Canadas healthcare [...]
Eidos Therapeutics Receives Positive Opinion for Orphan Designation from the European Medicines Agency for AG10, a Potent Oral Stabilizer for the Treatment of Transthyretin Amyloidosis
26/10/2018
SAN FRANCISCO, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), announced today that the Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) adopted [...]
AIT Therapeutics Appoints Douglas J. Beck as Chief Financial Officer
26/10/2018
Seasoned expert with three decades of financial planning and management experience to join AIT Team GARDEN CITY, N.Y., and REHOVOT, Israel, Oct. 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a [...]
Melinta Therapeutics to Report Third Quarter 2018 Financial Results on November 7, 2018
26/10/2018
NEW HAVEN, Conn., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Pages